VSee Health, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- VSee Health, Inc. (NASDAQ:VSEE) provides comprehensive telehealth care solutions, including a no-code, low-code SaaS platform through its VSee Lab subsidiary and acute care services via iDoc Virtual Telehealth Solutions, Inc.; the VSee platform enables customizable workflows for video visits, remote patient monitoring, patient engagement, clinician staffing, remote physical exams, AI-powered telenursing and telesitter solutions, revenue cycle management, scheduling, and seamless EHR integrations with features like omni-channel support, medical device streaming (such as digital otoscopes, EKGs, and ultrasounds), e-prescriptions, and online payments; iDoc delivers 24/7 teleneurointensivist care for neurointensive, cardiac surgery intensive, and general intensive care units treating stroke, brain trauma, spinal cord injuries, and other neurological conditions. Founded in 2008 and headquartered in Newton, Massachusetts, the company serves healthcare enterprises, hospitals, clinics, insurers, government entities, and federal clients across the United States with a focus on digital health transformation in health information services. Recent developments include robust Q3 2025 revenue growth to $3.98 million, up 19% year-over-year, driven by telehealth expansion and new contracts such as a three-year platform services agreement for virtual urgent care and behavioral health, public mental health services in a major U.S. county, and ongoing Southeast Asia initiatives like Project MAMA maternal health and TB screenings with partners Remedi, Inc. and iOne Resource in the Philippines; in 2024, VSee secured major contracts, expanded partnerships, and advanced AI-powered telehealth innovations amid projections for significant recurring revenue by mid-2026.
Company News
VSee Health Poised for Growth
VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings
VSEE Vertically Integrated Healthcare Commerce Platform
VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value
VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution
VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations
VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability
VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations
VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale
VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership
Short Interest in VSee Health, Inc. (NASDAQ:VSEE) Drops By 28.1%
VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet
VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026
VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery
EXCLUSIVE: Penny Stock VSEE Health Teams Up With GoMyRx To Expand Telehealth Drug Delivery
VSee and DocBox Announce Strategic Partnership to Launch the First Augmented Intelligence Platform for Virtual ICU
Critical Survey: Lightspeed Commerce (NYSE:LSPD) and VSee Health (NASDAQ:VSEE)
VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital
VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025
VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement